Ocuphire Pharma Inc. (OCUP)
NASDAQ: OCUP
· Real-Time Price · USD
1.17
-0.16 (-12.03%)
At close: Oct 23, 2024, 10:00 PM
Ocuphire Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -7.42M | -8.19M | -37.87M | -7.53M | -7.76M | -7.11M | -4.79M | 5.56M | -4.96M | -5.79M | 33.94M | -4.53M | -4.93M | -6.59M | -6.31M | -4.23M | -7.14M | -39.01M |
Depreciation & Amortization | 14K | 13K | 7K | n/a | n/a | n/a | 3K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |
Stock-Based Compensation | 896K | 913K | 860K | 776K | 806K | 985K | 711K | 573K | 1.42M | 804K | 424K | 493K | 445K | 445K | 479K | 478K | 463K | 494K |
Other Working Capital | 593K | n/a | n/a | 2.44M | 285K | 1.27M | -731K | 126K | 1.73M | 384K | -3.94M | -59K | 356K | -100K | -142K | 495K | 769K | -1.32M |
Other Non-Cash Items | -4.05M | -1.73M | 37.26M | 2K | 1.42M | 1.87M | -8.69M | -456K | -445K | 27K | 52K | -402K | 316K | 84K | 164K | -383K | 1.61M | 33.83M |
Deferred Income Tax | n/a | n/a | -8.67M | n/a | n/a | n/a | 8.67M | 1.73M | 445K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 294K | n/a | -8.71M | 1.62M | -333K | 395K | 8.65M | -10.42M | 4.53M | 1.31M | -5.63M | -486K | 663K | -105K | 23K | 550K | 730K | -1.12M |
Operating Cash Flow | -10.27M | -8.99M | -17.12M | -5.13M | -7.29M | -5.72M | 4.55M | -3M | 989K | -3.65M | 28.79M | -4.5M | -3.81M | -6.17M | -5.65M | -3.58M | -4.33M | -5.81M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100K | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 538K | -215K | n/a | 538K | n/a | n/a | n/a |
Common Stock Repurchased | 445K | 409K | 42K | n/a | n/a | -42K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 906K | 20.46M | 4.41M | -103K | -22K | -61K | -142K | -106K | n/a | n/a | -12K | -572K | -55K | -326K | -193K | -139K | -1.1M | 10K |
Financial Cash Flow | 906K | 20.46M | -3.33M | 353K | 1.54M | 2.38M | 3.6M | 5.38M | n/a | n/a | -12K | 1.33M | 1.59M | 882K | 8.03M | 1.6M | 17.96M | 10K |
Net Cash Flow | -9.36M | 11.47M | -11.09M | -4.78M | -5.75M | -3.34M | 8.15M | 2.37M | 989K | -3.65M | 28.78M | -3.17M | -2.22M | -5.29M | 2.28M | -1.98M | 13.64M | -5.8M |
Free Cash Flow | -10.27M | -8.99M | -17.12M | -5.13M | -7.29M | -5.72M | 4.55M | -3M | 989K | -3.65M | 28.79M | -4.5M | -3.81M | -6.17M | -5.75M | -3.58M | -4.33M | -5.81M |